Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Benedicte Delcoigne; Tine Iskov Kopp; Elizabeth Arkema; Karin Hellgren; Sella Aarrestad Provan; Heikki Relas; Kalle Aaltonen; Nina Trokovic; Bjorn Gudbjornsson; Gerdur Grondal; Eirik Klami Kristianslund; Jesper Lindhardsen; Lene Dreyer; Johan Askling

doi:10.1136/rmdopen-2022-002924

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling

HUS Inflammation Center

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	e002924
Journal	RMD open
Volume	9
Issue number	1
Number of pages	12
ISSN	2056-5933
DOIs	https://doi.org/10.1136/rmdopen-2022-002924
Publication status	Published - Feb 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

3121 General medicine, internal medicine and other clinical medicine

Access to Document

10.1136/rmdopen-2022-002924Licence: CC BY-NC

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritisFinal published version, 674 KBLicence: CC BY-NC

Cite this

Delcoigne, B., Kopp, T. I., Arkema, E., Hellgren, K., Provan, S. A., Relas, H., Aaltonen, K., Trokovic, N., Gudbjornsson, B., Grondal, G., Klami Kristianslund, E., Lindhardsen, J., Dreyer, L., & Askling, J. (2023). Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open, 9(1), Article e002924. https://doi.org/10.1136/rmdopen-2022-002924

@article{94c1648293574003a82c93f8318bd49d,

title = "Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers",

keywords = "Ankylosing, Arthritis, Psoriatic, Rheumatoid, Spondylitis, Tumor Necrosis Factor Inhibitors, 3121 General medicine, internal medicine and other clinical medicine",

author = "Benedicte Delcoigne and Kopp, {Tine Iskov} and Elizabeth Arkema and Karin Hellgren and Provan, {Sella Aarrestad} and Heikki Relas and Kalle Aaltonen and Nina Trokovic and Bjorn Gudbjornsson and Gerdur Grondal and {Klami Kristianslund}, Eirik and Jesper Lindhardsen and Lene Dreyer and Johan Askling",

year = "2023",

month = feb,

doi = "10.1136/rmdopen-2022-002924",

language = "English",

volume = "9",

journal = "RMD open",

issn = "2056-5933",

publisher = "BMJ PUBLISHING GROUP",

number = "1",

}

Delcoigne, B, Kopp, TI, Arkema, E, Hellgren, K, Provan, SA, Relas, H, Aaltonen, K, Trokovic, N, Gudbjornsson, B, Grondal, G, Klami Kristianslund, E, Lindhardsen, J, Dreyer, L & Askling, J 2023, 'Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers', RMD open, vol. 9, no. 1, e002924. https://doi.org/10.1136/rmdopen-2022-002924

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. / Delcoigne, Benedicte; Kopp, Tine Iskov; Arkema, Elizabeth et al.
In: RMD open, Vol. 9, No. 1, e002924, 02.2023.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis

T2 - a collaborative observational study across five Nordic rheumatology registers

AU - Delcoigne, Benedicte

AU - Kopp, Tine Iskov

AU - Arkema, Elizabeth

AU - Hellgren, Karin

AU - Provan, Sella Aarrestad

AU - Relas, Heikki

AU - Aaltonen, Kalle

AU - Trokovic, Nina

AU - Gudbjornsson, Bjorn

AU - Grondal, Gerdur

AU - Klami Kristianslund, Eirik

AU - Lindhardsen, Jesper

AU - Dreyer, Lene

AU - Askling, Johan

PY - 2023/2

Y1 - 2023/2

KW - Ankylosing

KW - Arthritis

KW - Psoriatic

KW - Rheumatoid

KW - Spondylitis

KW - Tumor Necrosis Factor Inhibitors

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1136/rmdopen-2022-002924

DO - 10.1136/rmdopen-2022-002924

M3 - Article

C2 - 36854568

SN - 2056-5933

VL - 9

JO - RMD open

JF - RMD open

IS - 1

M1 - e002924

ER -

Delcoigne B, Kopp TI, Arkema E, Hellgren K, Provan SA, Relas H et al. Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers. RMD open. 2023 Feb;9(1):e002924. doi: 10.1136/rmdopen-2022-002924